Abstract
Objective
To evaluate the effectiveness and safety of vaginal misoprostol for cervical priming prior to diagnostic hysteroscopy and to assess impact on pain scores and patient satisfaction.
Methods
One hundred women undergoing hysteroscopy were randomly allocated into two groups. The study group (n = 50) received 400 µg of misoprostol vaginally (self administered) 4–6 h prior to hysteroscopy while the control group (n = 50) did not receive any cervical priming. Primary outcome measured was need for cervical dilatation, analgesia or sedation. Secondary outcomes were pain scores, patient satisfaction and side effects.
Results
There was no significant difference in the need for cervical dilatation, analgesia or sedation in the two groups (P = 0.25, 0.64 and 0.5, respectively). In addition, there was no difference in subjective patient satisfaction (P = 0.70). However, those in the control group recorded a higher pain score (median ± SD = 5 ± 1.8) when compared to those who received misoprostol (median ± SD = 4.5 ± 2, P = 0.03). Only two women (4%) had bleeding per vaginum and one (2%) had a slight fever attributable to misoprostol.
Conclusion
Vaginal misoprostol prior to diagnostic hysteroscopy did not facilitate cervical dilatation. It did effect a reduction in pain scores, but there was no difference in patient satisfaction, need for analgesia or sedation. No significant side effects were reported.
Similar content being viewed by others
References
Barcaite E, Bartusevicius A, Railaite DR, Nadisauskiene R (2005) Vaginal misoprostol for cervical priming before hysteroscopy in perimenopausal and postmenopausal women. Int J Gynecol Obstet 91:141–145
Bisharah M, Al-fozan H, Tulandi T (2003) A randomized trial of sublingual misoprostol for cervical priming before hysteroscopy. J Am Assoc Gynecol Laparosc 10(3):390–391
Collins PW (1990) Misoprostol: discovery, development, and clinical applications. Med Rev Res 10:149–172
Cooper KG, Pinion SB, Bhattacharya S, Parkin DE (1996) The effects of the gonadotrophin releasing hormone analogue (goserelin) and prostaglandin E1 (misoprostol) on cervical resistance before transcervical resection of the endometrium. Br J Obstet Gynaecol 103:375–378
Fung TM, Lam MH, Wong SF, Ho LC (2002) A randomised placebo-controlled trial of vaginal misoprostol for cervical priming before hysteroscopy in postmenopausal women. Br J Obstet Gynaecol 109:561–565
Li YT, Chen TH, Kuo TC (2006) Cervical softening with vaginal misoprostol before hysterosalpingography. Eur J Obstet Gynecol Reprod Biol 134:130–131
Lokugamage AU, Refaey HE, Rodeck CH (2003) Misoprostol and pregnancy: ever-increasing indications of effective usage. Curr Opin Obstet Gynecol 15:513–518
Ngai SW, Tang OS, Lao T, Ho PC, Ma HK (1995) Oral misoprostol versus placebo for cervical dilatation before vacuum aspiration in first trimester of pregnancy. Hum Reprod 10:1220–1222
Preen AE, Mc-Keeby JL, Catherino W, Alvero RJ (2002) Oral misoprostol prior to operative hysteroscopy does not enhance cervical dilation or improve operative time: a prospective randomized, double blind, placebo-controlled trial. Fertil Steril 78(3):S79–S80
Preutthipan S, Herabutya Y (1999) A randomized controlled trial of vaginal misoprostol for cervical priming before hysteroscopy. Obstet Gynecol 94:427–430
Preutthipan S, Herabutya Y (2000) Vaginal misoprostol for cervical priming before operative hysteroscopy: a randomized controlled trial. Obstet Gynecol 96:890–894
Preutthipan S, Herabutya Y (2006) A randomized comparison of vaginal misoprostol and dinoprostone for cervical priming in nulliparous women before operative hysteroscopy. Fertil Steril 86:990–994
Singh K, Fong YF, Prasad RN, Dong F (1998) Randomized trial to determine optimal dose of vaginal misoprostol for preabortion cervical priming. Obstet Gynecol 92(5):795–798
Tang OS, Schweer H, Seyberth HW, Lee SW, Ho PC (2002) Pharmacokinetics of different routes of administration of misoprostol. Hum Reprod 17:332–336
Thomas JA, Leyland N, Durand N, Windrim RC (2002) The use of oral misoprostol as a cervical ripening agent in operative hysteroscopy: a double-blind, placebo-controlled trial. Am J Obstet Gynecol 186:876–879
Zieman M, Fong SK, Benowitz NL, Banskter D, Darney PD (1997) Absorption kinetics of misoprostol with oral or vaginal administration. Obstet Gynecol 90:88–92
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Singh, N., Ghosh, B., Naha, M. et al. Vaginal misoprostol for cervical priming prior to diagnostic hysteroscopy––efficacy, safety and patient satisfaction: a randomized controlled trial. Arch Gynecol Obstet 279, 37–40 (2009). https://doi.org/10.1007/s00404-008-0666-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-008-0666-8